Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Jentzen

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
European Radiology|July 3, 2004
Value of (124)I-PET/CT in staging of patients with differentiated thyroid cancerL S Freudenberg, G Antoch, W Jentzen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 3, 2003
FDG-PET/CT in re-staging of patients with lymphomaL S Freudenberg, G Antoch, P Schütt, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 27, 2009
Thyroid remnant dose: 124I-PET/CT dosimetric comparison of rhTSH versus thyroid hormone withholding before radioiodine remnant ablation in differentiated thyroid cancerL S Freudenberg, C Frömke, T Petrich, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2026
Inter-center variability of dosimetry methodology and the impact on reported absorbed dose for [<sup>177</sup>Lu]Lu-PSMA-617 therapyB J R Timmermans, B M Privé, R Hofferber, et al.
Physics in Medicine and Biology|September 17, 2021
Can a ToF-PET photon attenuation reconstruction test stopping-power estimations in proton therapy? A phantom studyC Bäumer, C M Bäcker, M Conti, et al.
Physics in Medicine and Biology|November 9, 2017
Quantitative performance evaluation of <sup>124</sup>I PET/MRI lesion dosimetry in differentiated thyroid cancerR Wierts, W Jentzen, H H Quick, et al.
Journal of the American Chemical Society|June 9, 2016
Ruffling in a Series of Nickel(II) meso-Tetrasubstituted Porphyrins as a Model for the Conserved Ruffling of the Heme of Cytochromes cW Jentzen, M C Simpson, J D Hobbs, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
European Radiology|July 3, 2004
Value of (124)I-PET/CT in staging of patients with differentiated thyroid cancerL S Freudenberg, G Antoch, W Jentzen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 3, 2003
FDG-PET/CT in re-staging of patients with lymphomaL S Freudenberg, G Antoch, P Schütt, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 27, 2009
Thyroid remnant dose: 124I-PET/CT dosimetric comparison of rhTSH versus thyroid hormone withholding before radioiodine remnant ablation in differentiated thyroid cancerL S Freudenberg, C Frömke, T Petrich, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2026
Inter-center variability of dosimetry methodology and the impact on reported absorbed dose for [<sup>177</sup>Lu]Lu-PSMA-617 therapyB J R Timmermans, B M Privé, R Hofferber, et al.
Physics in Medicine and Biology|September 17, 2021
Can a ToF-PET photon attenuation reconstruction test stopping-power estimations in proton therapy? A phantom studyC Bäumer, C M Bäcker, M Conti, et al.
Physics in Medicine and Biology|November 9, 2017
Quantitative performance evaluation of <sup>124</sup>I PET/MRI lesion dosimetry in differentiated thyroid cancerR Wierts, W Jentzen, H H Quick, et al.
Journal of the American Chemical Society|June 9, 2016
Ruffling in a Series of Nickel(II) meso-Tetrasubstituted Porphyrins as a Model for the Conserved Ruffling of the Heme of Cytochromes cW Jentzen, M C Simpson, J D Hobbs, et al.
Pageof 3